What’s Equity Crowdfunding And Why Does It Matter Now?
The window closes on August 27, and the price is $3.00/
Is “AGI” Just the AI World’s Favorite Fairy Tale?
OpenAI’s CEO, Sam Altman, just pulled a move you rarely see
Is This Biotech Really Funded by the People, Not Wall Street?
Final Countdown: Cytonics’ Reg A+ Raise Closes August 27th.
Most biotech cap
Is Google Handing Chrome to a Startup Nobody Can Spell?
Perplexity AI, a shiny new tech startup, just slapped a $34.5
What Makes Cytonics Different And Why Should You Trust Them?
Because in biotech, the “who” matters just as much as the “what”
Is Apple Picking Its Favorite AI Like It’s Choosing a Favorite Child?
Elon Musk says Apple is playing favorites in the App Store, and
Did OpenAI Just Learn That “Smarter” AI Isn’t Always Better?
OpenAI just pulled the tech version of taking your favorite menu item,
Why Did Big Pharma Spend Billions and Still Fail at OA?
Because when you treat a forest fire like a sunburn… it doesn’
Did Duolingo Just Win the AI Backlash Game?
Back in April, Duolingo pulled the kind of stunt that makes the
What’s Next And Why This Is a Major Inflection Point
Because in biotech, timing isn’t just everything, it’s everything and
Can Hollywood Keep AI Out?
Universal is slapping a new line in movie end credits that basically
Is This the First True Disease-Modifying Drug for OA?
Because “disease-modifying” isn’t just a label, it’s the holy grail.